BioSpecifics
is a New York-based biopharmaceutical company that develops injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease... Read moreBioSpecifics
is a New York-based biopharmaceutical company that develops injectable collagenase for the treatment of Dupuytren's contracture and Peyronie's disease... Read more
CEO
Add
News
Dec 02, 2020
The Business Journals: Philadelphia
BioSpecifics: Endo completes $540 million acquisition of BioSpecifics
Nov 18, 2020
Micro Small Cap
BioSpecifics: BioSpecifics Merger Investigation: Halper Sadeh LLP Encourages BioSpecifics Technologies Corp. Shareholders to Contact the Firm - BSTC
Nov 13, 2020
Micro Small Cap
BioSpecifics: Moore Kuehn Encourages BSTC Investors to Contact Law Firm
Nov 13, 2020
NewsFile
Press Release: BioSpecifics : Moore Kuehn Encourages BSTC Investors to Contact Law Firm
Nov 11, 2020
Benzinga
BioSpecifics: Rigrodsky & Long, P.A. Reminds Investors Of Investigation of BioSpecifics Technologies Corp. Buyout
Nov 10, 2020
GlobalNewswire
Press Release: BioSpecifics : Rigrodsky & Long, P.A. Reminds Investors Of Investigation of BioSpecifics Technologies Corp. Buyout
Nov 09, 2020
NewsOk
BioSpecifics: BioSpecifics: 3Q Earnings Snapshot
Nov 06, 2020
Micro Small Cap
BioSpecifics: SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors Of Investigation of BioSpecifics Technologies Corp. Buyout
Nov 04, 2020
PR Newswire
Press Release: BioSpecifics : SHAREHOLDER ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm - EIGI, TNAV, ALSK, BSTC, CXO
Nov 04, 2020
Micro Small Cap
BioSpecifics: SHAREHOLDER ALERT: WeissLaw LLP Investigates BioSpecifics Technologies Corp.
BioSpecifics Competitors
1
2
3
4
5
6
7
8
9
10